Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronnie C Mease

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 28, 2016
(2S)-2-(3-(1-Carboxy-5-(4-211At-Astatobenzamido)Pentyl)Ureido)-Pentanedioic Acid for PSMA-Targeted α-Particle Radiopharmaceutical TherapyAna P Kiess, Il Minn, Ganesan Vaidyanathan, et al.
Nuclear Medicine and Biology|May 18, 2013
Radiochemical synthesis and in vivo evaluation of [18F]AZ11637326: an agonist probe for the α7 nicotinic acetylcholine receptorHayden T Ravert, Peter Dorff, Catherine A Foss, et al.
Molecular Imaging and Biology|April 22, 2015
Initial Evaluation of [(18)F]DCFPyL for Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate CancerZsolt Szabo, Esther Mena, Steven P Rowe, et al.
ACS Infectious Diseases|August 2, 2018
Positron Emission Tomography Imaging with 2-[<sup>18</sup>F]F- p-Aminobenzoic Acid Detects Staphylococcus aureus Infections and Monitors Drug ResponseZhuo Zhang, Alvaro A Ordonez, Hui Wang, et al.
AJR. American Journal of Roentgenology|August 7, 2020
Prospective Evaluation of <sup>18</sup>F-DCFPyL PET/CT in Detection of High-Risk Localized Prostate Cancer: Comparison With mpMRISonia Gaur, Esther Mena, Stephanie A Harmon, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 11, 2021
Pharmacodynamic measures within tumors expose differential activity of PD(L)-1 antibody therapeuticsDhiraj Kumar, Akhilesh Mishra, Ala Lisok, et al.
Oncotarget|July 21, 2016
[64Cu]XYIMSR-06: A dual-motif CAIX ligand for PET imaging of clear cell renal cell carcinomaIl Minn, Soo Min Koo, Hye Soo Lee, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 24, 2015
Comparison of Prostate-Specific Membrane Antigen-Based 18F-DCFBC PET/CT to Conventional Imaging Modalities for Detection of Hormone-Naïve and Castration-Resistant Metastatic Prostate CancerSteven P Rowe, Katarzyna J Macura, Anthony Ciarallo, et al.
Oncotarget|February 1, 2019
A comparison of prostate cancer bone metastases on <sup>18</sup>F-Sodium Fluoride and Prostate Specific Membrane Antigen (<sup>18</sup>F-PSMA) PET/CT: Discordant uptake in the same lesionStephanie A Harmon, Esther Mena, Joanna H Shih, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 1, 2018
A Prospective Comparison of <sup>18</sup>F-Sodium Fluoride PET/CT and PSMA-Targeted <sup>18</sup>F-DCFBC PET/CT in Metastatic Prostate CancerStephanie A Harmon, Ethan Bergvall, Esther Mena, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 28, 2016
(2S)-2-(3-(1-Carboxy-5-(4-211At-Astatobenzamido)Pentyl)Ureido)-Pentanedioic Acid for PSMA-Targeted α-Particle Radiopharmaceutical TherapyAna P Kiess, Il Minn, Ganesan Vaidyanathan, et al.
Nuclear Medicine and Biology|May 18, 2013
Radiochemical synthesis and in vivo evaluation of [18F]AZ11637326: an agonist probe for the α7 nicotinic acetylcholine receptorHayden T Ravert, Peter Dorff, Catherine A Foss, et al.
Molecular Imaging and Biology|April 22, 2015
Initial Evaluation of [(18)F]DCFPyL for Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate CancerZsolt Szabo, Esther Mena, Steven P Rowe, et al.
ACS Infectious Diseases|August 2, 2018
Positron Emission Tomography Imaging with 2-[<sup>18</sup>F]F- p-Aminobenzoic Acid Detects Staphylococcus aureus Infections and Monitors Drug ResponseZhuo Zhang, Alvaro A Ordonez, Hui Wang, et al.
AJR. American Journal of Roentgenology|August 7, 2020
Prospective Evaluation of <sup>18</sup>F-DCFPyL PET/CT in Detection of High-Risk Localized Prostate Cancer: Comparison With mpMRISonia Gaur, Esther Mena, Stephanie A Harmon, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 11, 2021
Pharmacodynamic measures within tumors expose differential activity of PD(L)-1 antibody therapeuticsDhiraj Kumar, Akhilesh Mishra, Ala Lisok, et al.
Oncotarget|July 21, 2016
[64Cu]XYIMSR-06: A dual-motif CAIX ligand for PET imaging of clear cell renal cell carcinomaIl Minn, Soo Min Koo, Hye Soo Lee, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 24, 2015
Comparison of Prostate-Specific Membrane Antigen-Based 18F-DCFBC PET/CT to Conventional Imaging Modalities for Detection of Hormone-Naïve and Castration-Resistant Metastatic Prostate CancerSteven P Rowe, Katarzyna J Macura, Anthony Ciarallo, et al.
Oncotarget|February 1, 2019
A comparison of prostate cancer bone metastases on <sup>18</sup>F-Sodium Fluoride and Prostate Specific Membrane Antigen (<sup>18</sup>F-PSMA) PET/CT: Discordant uptake in the same lesionStephanie A Harmon, Esther Mena, Joanna H Shih, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 1, 2018
A Prospective Comparison of <sup>18</sup>F-Sodium Fluoride PET/CT and PSMA-Targeted <sup>18</sup>F-DCFBC PET/CT in Metastatic Prostate CancerStephanie A Harmon, Ethan Bergvall, Esther Mena, et al.
Pageof 8